Exacerbation of diabetic nephropathy mimicking thrombotic microangiopathy during sunitinib treatment for metastatic renal cell carcinoma

Thrombotic Microangiopathy ◽

Renal Cell ◽

Prognostic and Predictive Value of Hematologic Parameters in Patients with Metastatic Renal Cell Carcinoma: Second Line Sunitinib Treatment Following IFN-alpha

Asian Pacific Journal of Cancer Prevention ◽

10.7314/apjcp.2013.14.3.2101 ◽

2013 ◽

Vol 14 (3) ◽

pp. 2101-2105 ◽

Cited By ~ 20

Author(s):

Ahmet Dirican ◽

Yuksel Kucukzeybek ◽

Cigdem Erten ◽

Isil Somali ◽

Lutfiye Demir ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Predictive Value ◽

Renal Cell ◽

Second Line ◽

Sunitinib Treatment ◽

Ifn Alpha

A Case of Acute Adrenal Insufficiency Unmasked During Sunitinib Treatment for Metastatic Renal Cell Carcinoma

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hys070 ◽

2012 ◽

Vol 42 (8) ◽

pp. 764-766 ◽

Cited By ~ 2

Author(s):

T. Yoshino ◽

K. Kawai ◽

J. Miyazaki ◽

T. Kimura ◽

A. Ikeda ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Adrenal Insufficiency ◽

Renal Cell ◽

Sunitinib Treatment ◽

Acute Adrenal Insufficiency

Abscess formation mimicking disease progression, in a patient with metastatic renal cell carcinoma during sunitinib treatment

World Journal of Surgical Oncology ◽

10.1186/1477-7819-8-45 ◽

2010 ◽

Vol 8 (1) ◽

Cited By ~ 2

Author(s):

Vasiliki Michalaki ◽

Nikolaos Arkadopoulos ◽

Agathi Kondi-Pafiti ◽

Constantine Gennatas

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Disease Progression ◽

Renal Cell ◽

Abscess Formation ◽

Brain natriuretic peptide precursor (NT-pro-BNP) levels predict for clinical benefit to sunitinib treatment in patients with metastatic renal cell carcinoma

BMC Cancer ◽

10.1186/1471-2407-10-489 ◽

2010 ◽

Vol 10 (1) ◽

Cited By ~ 4

Author(s):

Konstantinos T Papazisis ◽

Lukas F Kontovinis ◽

Christos N Papandreou ◽

George Kouvatseas ◽

Christos Lafaras ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Brain Natriuretic Peptide ◽

Cell Carcinoma ◽

Natriuretic Peptide ◽

Clinical Benefit ◽

Renal Cell ◽

Sunitinib Treatment ◽

Peptide Precursor

Temporal cessation of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective study.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e15552 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e15552-e15552 ◽

Cited By ~ 2

Author(s):

Yuji Miura ◽

Yoichi Fujii ◽

Akihiko Shimomura ◽

Naoki Sudo ◽

Masaomi Ikeda ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Retrospective Study ◽

Cell Carcinoma ◽

Renal Cell ◽

Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2016.04.012 ◽

2016 ◽

Vol 14 (5) ◽

pp. 420-425 ◽

Cited By ~ 7

Author(s):

Daniel Keizman ◽

Maya Ish-Shalom ◽

Avishay Sella ◽

Maya Gottfried ◽

Natalie Maimon ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Sunitinib Treatment ◽

Patients With Diabetes

Long-Term Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma: A Pooled Analysis of Clinical Trials

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2017.06.005 ◽

2018 ◽

Vol 16 (1) ◽

pp. 6-12.e4 ◽

Cited By ~ 6

Author(s):

Nizar M. Tannir ◽

Robert A. Figlin ◽

Martin E. Gore ◽

M. Dror Michaelson ◽

Robert J. Motzer ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Clinical Trials ◽

Cell Carcinoma ◽

Renal Cell ◽

Pooled Analysis ◽

Sunitinib Treatment ◽

Term Response

S&T-55 SARCOPENIA AND THE MODIFIED GLASGOW PROGNOSTIC SCORE ARE SIGNIFICANT PREDICTORS OF PATIENT SURVIVAL IN METASTATIC RENAL CELL CARCINOMA PATIENTS RECEIVING FIRST-LINE SUNITINIB TREATMENT

The Journal of Urology ◽

10.1016/j.juro.2016.02.2884 ◽

2016 ◽

Vol 195 (4S) ◽

Author(s):

Hiroki Ishihara ◽

Tsunenori Kondo ◽

Kenji Omae ◽

Toshio Takagi ◽

Jumpei Iizuka ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Patient Survival ◽

Prognostic Score ◽

Glasgow Prognostic Score ◽

First Line ◽

Sunitinib Treatment ◽

Modified Glasgow Prognostic Score

Use of the UCLA-integrated staging system (UISS) to predict survival after sunitinib treatment for patients with metastatic renal cell carcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.4593 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 4593-4593 ◽

Cited By ~ 1

Author(s):

F. Pouliot ◽

C. Anterasian ◽

T. Klatte ◽

D. Finley ◽

B. Shuch ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Staging System ◽

Changes in lymphocytic populations and autoantibodies resulting from sunitinib treatment of metastatic renal cell carcinoma (mRCC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e15085 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e15085-e15085

Author(s):

A. Karadimou ◽

M. Tsiatas ◽

N. Gavalas ◽

G. Lainakis ◽

E. Terpos ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽